Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.93
-0.0100-0.03%
Post-market: 30.070.1450+0.48%17:25 EDT
Volume:5K
Turnover:160.19K
Market Cap:31.42M
PE:- -
High:30.15
Open:29.82
Low:29.79
Close:29.94
52wk High:33.59
52wk Low:23.00
Shares:1.05M
Float Shares:1.05M
Volume Ratio:0.20
T/O Rate:0.51%
Dividend:0.07
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Press Release: Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook

Dow Jones
·
Aug 06

Oscar Health Stock Has Doubled This Year. the ACA Insurer Reports Thursday.

Dow Jones
·
Aug 06

Tempus AI CEO, Data Ryan Fukushima Reports Disposal of 23,818 Common Shares Worth $1.1 Million

Reuters
·
Aug 06

Moderately bullish activity in Hims and Hers Health with shareslittle changed

TIPRANKS
·
Aug 05

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-05

Reuters
·
Aug 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (OtherNURPF), Mettler-Toledo (MTD) and Dexcom (DXCM)

TIPRANKS
·
Aug 05

True Health Medical Surges Over 14% to a Record High, Driving AI and Digital Healthcare Expansion

Deep News
·
Aug 05

Top IQVIA Execs Quietly Cash In on Major Stock Move

TIPRANKS
·
Aug 05

Hinge Health Posts Record Q2 Results, Raises Outlook

TIPRANKS
·
Aug 05

IQVIA President MedTech and Consumer Health Bhavik Patel Sells 1,855 Shares for $436,927.85

Reuters
·
Aug 05

IQVIA Partners with Medera to Advance Cardiac Gene Therapy Development

Reuters
·
Aug 05

DexCom Director Mark G. Foletta Disposes of 4,000 Common Shares Worth $330,640

Reuters
·
Aug 05

Gartner Inc. Stock Climbs 22.6%, Outperforms Peers

Dow Jones
·
Aug 05

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

THOMSON REUTERS
·
Aug 05

Analysts’ Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)

TIPRANKS
·
Aug 04

Oscar Health Inc Expected to Post Earnings of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Tempus AI announces study results of PRISM2

TIPRANKS
·
Aug 04

Tempus AI Inc : Btig Cuts Target Price to $70 from $80

THOMSON REUTERS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 04

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

TIPRANKS
·
Aug 04